Lindsey Wahlstrom-Edwards

Delivering on Diversity: Clinical Trials and Healthcare Access

Clinical trials help people access tomorrow’s treatments today. In the age of precision medicine and tumor profiling, this statement is particularly true for oncology patients. According to a recent ProPublica article, even in Phase I trials, 20% of clinical trial participants now see a reduction in tumor size, compared with 5% of participants in the 1990s. Read more

Topics: Podcast

Delivering on Diversity: Tuskegee and what it means for minority participation in medical research today

Every conversation about minority participation in medical research inevitably  winds up with the “T” word – Tuskegee. Read more

Topics: Podcast

Research Pioneers: Meet Allison Kalloo

At Antidote, we aim to make it easy for researchers and patients to connect. And a big part of that work is creating opportunities for people to learn more about medical research and dispelling myths about medical research participation, both for patients and researchers. Read more

Topics: Podcast

Experts Sound Off: Minority Participation in Medical Research

Increasingly, medical researchers acknowledge the need for more diversity in study participants so that trials can better predict the real-world impact of a drug or medical device. Yet a big question remains: How can researchers better reach diverse populations to drive minority participation in medical research? Read more

Patient Advocates Weigh In: Why lupus clinical trials need more minority participants

Minority participation in medical research is important for all conditions, but is critical for ailments that disproportionately impact people of color, like lupus. Read more

Cures for All of Us: Lupus Patient and Clinical Trial Volunteer on the Frontlines for Diversity in Research

In the end, it was vanity that brought Shanelle Gabriel to the doctor who diagnosed her lupus. At least that’s how she tells it. Read more

Meet Five Mothers of Medical Research

The aim of medical research is to drive the development of new treatments and cures for diseases. But how are priorities set? Why do some diseases receive more funding for research than others? The answer, in part, is through the work of health advocates who lobby Congress for government funding and establish foundations of their own to fund research studies. Today we celebrate five mothers who ... Read more

A brush of inspiration: A talk with patient advocate Regina Holliday

The hall was full of people clad in conference attire: black suits, white shirts, and, for some, an adventurous pop of color in a shoe or a tie. Read more

Topics: Podcast

Bridging the gap between lupus researchers and patients to identify new lupus treatment options

On March 6th, Antidote’s partners Lupus and Allied Diseases Association and Lupus Research Alliance, along with the Lupus Foundation of America, released the Lupus Patient Voices report. Read more

Research to policy: Fighting for Minnesotans living with rare diseases

When Erica Barnes founded Chloe's Fight Rare Disease Foundation along with her husband, Philip, in 2014, she had two goals: Read more